Full Answer
Who is Arbor Biotechnologies?
Paul Meister is Chairman of Arbor Biotechnologies, Inc and co-founder of Liberty Lane Partners, LLC, a private investment company with investment holdings in life science, diagnostic and healthcare-related businesses.
How much did Arbor Realty Trust sell in its IPO?
UNIONDALE, N.Y., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (the “Company”) (NYSE: ABR) announced today that it priced its public offering of 7,500,000 shares of common stock for total expected gross proceeds of approximately $147.8 million before underwriting discounts and commissions and expenses.
Will Arbor Realty Trust (ABR) gain on rising earnings in September 2021?
ABR earnings call for the period ending September 30, 2021. Arbor Realty Trust (ABR) delivered earnings and revenue surprises of 27.03% and 7.34%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Who is the founder of Arbor?
Prior to co-founding Arbor, David completed his PhD in the laboratory of Feng Zhang at MIT and the Broad Institute, where he contributed to the early development of CRISPR-Cas systems for mammalian genome editing applications.
See more
Arbor Biotechnologies Comparisons
Developer of transformative therapeutic products designed to improve human health and sustainability. The company's prod
Arbor Biotechnologies Signals
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
